Russell Investments Group, Ltd. Forma Therapeutics Holdings, Inc. Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$7.12 - $20.24 $741,818 - $2.11 Million	-104,188 Reduced 98.2%	1,913 $38,000
Q2 2022 Jul 29, 2022	BUY	$5.1 - $10.0 $447,917 - $878,270	87,827 Added 480.61%	106,101 $730,000
Q1 2022 May 05, 2022	BUY	$8.34 - $14.69 $152,405 - $268,445	18,274 New	18,274 $169,000
Q2 2021 Aug 04, 2021	SELL	$22.86 - $30.95 $355,244 - $480,963	-15,540 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$24.58 - $42.82 $234,370 - $408,288	-9,535 Reduced 38.03%	15,540 $435,000
Q4 2020 Feb 08, 2021	BUY	$34.9 - $51.08 $875,117 - $1.28 Million	25,075 New	25,075 $881,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.